Development of G-quadruplex Stabilizers as Anticancer Drug Therapy and Selective Agonists of the Human Oxytocin Receptor as a Therapeutic Tool for Neuropsychiatric Disorders

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Unknown venue

• Publication date

  2010-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The hallmarks of cancer

  2012cited by this paper
• Transactions

  2011cited by this paper
• Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist.

  2010cited by this paper
• Intranasal oxytocin increases positive communication and reduces cortisol levels during couple conflict.

  2009cited by this paper
• BRACO19 analog dimers with improved inhibition of telomerase and hPot 1.

  2009influential reference
• Involvement of oxytocin and its receptor in nociceptive modulation in the central nucleus of amygdala of rats.

  2009cited by this paper
• Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.

  2009cited by this paper
• Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice

  2009influential reference
• Role of oxytocin/oxytocin receptor system in regulation of cell growth and neoplastic processes.

  2009cited by this paper
• Oxytocin enhances processing of positive versus negative emotional information in healthy male volunteers

  2009cited by this paper
• Prepulse inhibition and genetic mouse models of schizophrenia.

  2009cited by this paper
• Impaired sociability and cognitive function in Nrcam-null mice.

  2009cited by this paper
• Oxytocin: the great facilitator of life.

  2009influential reference
• Oxytocin stimulates in vitro angiogenesis via a Pyk-2/Src-dependent mechanism.

  2009cited by this paper
• Does oxytocin influence the early detection of angry and happy faces?

  2009cited by this paper
• Affinity and efficacy of selective agonists and antagonists for vasopressin and oxytocin receptors: an "easy guide" to receptor pharmacology.

  2008cited by this paper
• Behavioural studies using temporal and spatial inactivation of the oxytocin receptor.

  2008cited by this paper
• Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting.

  2008cited by this paper
• A conditional knockout mouse line of the oxytocin receptor.

  2008influential reference
• Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits.

  2008influential reference
• From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long‐term adverse consequences of drug use?

  2008cited by this paper
• Oxytocin and cortisol in romantically unattached young adults: associations with bonding and psychological distress.

  2008cited by this paper
• Post-learning intranasal oxytocin modulates human memory for facial identity.

  2008cited by this paper
• Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.

  2008cited by this paper
• Genes controlling affiliative behavior as candidate genes for autism.

  2008cited by this paper
• The acute effects of intranasal oxytocin administration on endocrine and sexual function in males.

  2008cited by this paper
• Attachment, aggression and affiliation: the role of oxytocin in female social behavior.

  2008cited by this paper
• Mouse Behavioral Tasks Relevant to Autism: Phenotypes of Ten Inbred Strains

  2008influential reference
• Association between the oxytocin receptor (OXTR) gene and autism: relationship to Vineland Adaptive Behavior Scales and cognition

  2008cited by this paper
• Further studies in the developmental hyperserotonemia model (DHS) of autism: social, behavioral and peptide changes.

  2008cited by this paper
• Oxytocin shapes the neural circuitry of trust and trust adaptation in humans.

  2008cited by this paper
• Oxytocin receptors: ligand binding, signalling and cholesterol dependence.

  2008cited by this paper
• Influence of oxytocin or epidural analgesia on personality profile in breastfeeding women: a comparative study

  2008cited by this paper
• Oxytocin knockout mice: a model for studying stress-related and ingestive behaviours.

  2008cited by this paper
• A hitchhiker's guide to G-quadruplex ligands.

  2008cited by this paper
• Male anorgasmia treated with oxytocin.

  2008cited by this paper
• Developing drugs for core social and communication impairment in autism.

  2008cited by this paper
• Development of a mouse test for repetitive, restricted behaviors: relevance to autism.

  2008cited by this paper
• Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands.

  2008cited by this paper
• Oxytocin-induced antinociception in the spinal cord is mediated by a subpopulation of glutamatergic neurons in lamina I-II which amplify GABAergic inhibition

  2008cited by this paper
• Synthesis and SAR of selective muscarinic acetylcholine receptor subtype 1 (M1 mAChR) antagonists.

  2008cited by this paper
• An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission.

  2008cited by this paper
• Functional selectivity in GPCR modulator screening.

  2008cited by this paper
• Evidence of Dysregulated Peripheral Oxytocin Release Among Depressed Women

  2008cited by this paper
• The role of oxytocin in neuropsychiatric disorders.

  2008influential reference
• Ethnicity is associated with alterations in oxytocin relationships to pain sensitivity in women

  2008cited by this paper
• Social approach and repetitive behavior in eleven inbred mouse strains.

  2008cited by this paper
• Oxytocin Attenuates Affective Evaluations of Conditioned Faces and Amygdala Activity

  2008cited by this paper
• PRIORITY COMMUNICATION-BRIEF REPORT Oxytocin Increases Gaze to the Eye Region of Human Faces

  2008cited by this paper
• Oxytocin enhances the encoding of positive social memories in humans.

  2008cited by this paper
• Physiological relevance of telomeric G‐quadruplex formation: a potential drug target

  2007cited by this paper
• The human telomere and its relationship to human disease, therapy, and tissue engineering.

  2007cited by this paper
• Extracellular amino acid levels in the paraventricular nucleus and the central amygdala in high- and low-anxiety dams rats during maternal aggression: Regulation by oxytocin

  2007cited by this paper
• Reporting data from high-throughput screening of small-molecule libraries.

  2007influential reference
• Plasma oxytocin levels and anxiety in patients with major depression.

  2007cited by this paper
• Circular dichroism to determine binding mode and affinity of ligand–DNA interactions

  2007cited by this paper
• Low- to high-throughput analysis of telomerase modulators with Telospot

  2007influential reference
• Oxytocin Increases Generosity in Humans

  2007cited by this paper
• Sensorimotor gating deficits in adults with autism.

  2007cited by this paper
• Central oxytocin enhances antinociception in the rat.

  2007cited by this paper
• Association of the oxytocin receptor gene (OXTR) in Caucasian children and adolescents with autism.

  2007cited by this paper
• A Critical Review of Pharmaceutical Galactagogues

  2007cited by this paper
• Effect of oxytocin on acupuncture analgesia in the rat.

  2007cited by this paper
• Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors.

  2007cited by this paper
• Interrogation of G-quadruplex-protein interactions.

  2007cited by this paper
• Sensitivity to intranasal oxytocin in adult men with early parental separation.

  2007cited by this paper
• Structure-specific recognition of quadruplex DNA by organic cations: influence of shape, substituents and charge.

  2007cited by this paper
• Reevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action

  2007cited by this paper
• Peripherally administered non-peptide oxytocin antagonist, L368,899, accumulates in limbic brain areas: a new pharmacological tool for the study of social motivation in non-human primates.

  2007cited by this paper
• Social approach behaviors in oxytocin knockout mice: comparison of two independent lines tested in different laboratory environments.

  2007influential reference
• GPCR functional selectivity has therapeutic impact.

  2007cited by this paper
• CD38 is critical for social behaviour by regulating oxytocin secretion

  2007cited by this paper
• Energetics of quadruplex-drug recognition in anticancer therapy.

  2007cited by this paper
• Agonist selectivity in the oxytocin/vasopressin receptor family: new insights and challenges.

  2007cited by this paper
• Evidence for a Neuroendocrinological Foundation of Human Affiliation

  2007cited by this paper
• Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology.

  2007cited by this paper
• Oxytocin increases retention of social cognition in autism.

  2007cited by this paper
• The status of pharmacotherapy for autism spectrum disorders

  2007cited by this paper
• Introduction to the pharmaceutical sciences

  2007influential reference
• Oxytocin improves "mind-reading" in humans.

  2007cited by this paper
• Anxiety, cortisol, and attachment predict plasma oxytocin.

  2007cited by this paper
• Emerging Concepts of Guanine Nucleotide-Binding Protein-Coupled Receptor (GPCR) Function and Implications for High Throughput Screening

  2007cited by this paper
• Oxytocin during pregnancy and early postpartum: individual patterns and maternal-fetal attachment.

  2007cited by this paper
• Challenges in the development of mGluR5 positive allosteric modulators: the discovery of CPPHA.

  2007cited by this paper
• A Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 2 Blocks a Hallucinogenic Drug Model of Psychosis

  2007cited by this paper
• Testing Hypotheses About Autism

  2007cited by this paper
• Search for autism loci by combined analysis of Autism Genetic Resource Exchange and Finnish families

  2006cited by this paper
• Aggressive behavior linked to corticotropin-reactive autoantibodies.

  2006cited by this paper
• Convergence and Divergence in the Neurochemical Regulation of Prepulse Inhibition of Startle and N40 Suppression in Rats

  2006cited by this paper
• Statistical practice in high-throughput screening data analysis

  2006cited by this paper
• Quadruplex DNA: sequence, topology and structure

  2006cited by this paper
• Screening the receptorome

  2006cited by this paper
• Quantification of isozyme-specific activation of phospholipase C-beta2 by Rac GTPases and phospholipase C-epsilon by Rho GTPases in an intact cell assay system.

  2006cited by this paper
• 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 3. Synthesis, pharmacokinetics, and in vivo potency.

  2006cited by this paper
• Vasopressin interactions with oxytocin in the control of female sexual behavior.

  2006cited by this paper
• Mouse models of autism spectrum disorders: The challenge for behavioral genetics

  2006cited by this paper
• Plasma oxytocin levels in depression and their correlation with the temperament dimension of reward dependence

  2006cited by this paper
• Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications

  2006influential reference
• Pyridyl-2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists: synthesis, pharmacokinetics, and in vivo potency.

  2006cited by this paper
• Sulforhodamine B colorimetric assay for cytotoxicity screening

  2006cited by this paper

• No citing papers are available for this paper.